This inventor holds 1 USPTO granted patent. Top assignee: Washington University. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Jason Ulrich: Innovator in Anti-TREM-2 Agonist Antibodies
Introduction
Jason Ulrich is a notable inventor based in St. Louis, MO. He has made significant contributions to the field of biomedical research, particularly in the development of therapeutic antibodies.
Latest Patents
Ulrich holds a patent for anti-TREM-2 agonist antibodies. This patent encompasses antibodies that promote TREM-2 activation and outlines methods for using these antibodies therapeutically. His innovative work in this area has the potential to impact various therapeutic applications.
Career Highlights
Jason Ulrich is affiliated with Washington University, where he conducts his research. His work is characterized by a commitment to advancing scientific knowledge and developing new therapeutic strategies.
Collaborations
He collaborates with esteemed colleagues, including Hong Jiang and David Michael Holtzman, to further enhance the impact of his research.
Conclusion
Jason Ulrich's contributions to the field of anti-TREM-2 agonist antibodies exemplify the innovative spirit of modern biomedical research. His work continues to pave the way for new therapeutic possibilities.